MedPharm Ltd
Business Centre
Sheep Street
Charlbury
OX7 3RR
United Kingdom
Tel: 44-0-16-0881-9267
Fax: 44-0-16-0881-9268
Website: http://www.medpharm.co.uk/
27 articles about MedPharm Ltd
-
MedPharm Welcomes New Board Members, Appoints Industry Veteran Patrick Walsh as Executive Chairman
2/26/2024
MedPharm, a global topical and transdermal CDMO, announced several Board changes, including the appointment of Patrick Walsh as Executive Chairman.
-
MedPharm, Ltd. Appoints Lynn Allen as Chief Executive Officer
1/18/2024
MedPharm, a global topical and transdermal CDMO, announced that Lynn Allen has been named Chief Executive Officer, effective January 1, 2024.
-
Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.
-
MedPharm Officially Splits From Schwazze
9/30/2020
MedPharm Holdings, a leading medical cannabis manufacturer, R&D laboratory, and compounding facility, announced today they will not be extending their term sheet for acquisition with Schwazze, Inc. (SHWZ), formerly operating as Medicine Man Technologies. The term sheet expires today, September 30, 2020. “After more than a year and a half of negotiations we have mutually agreed with Schwazze, this transaction no longer s
-
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
-
Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating Alzheimer’s with Cannabis
12/5/2019
The study will encompass patient surveys, memory tests, caregiver surveys, brain scans, and blood tests.
-
Colorado’s MedPharm Clears Significant DEA Hurdle for Federal Cannabis Research License
8/27/2019
MedPharm Research, the leader in cannabis research and formulation development, was notified by the Drug Enforcement Administration that it had been selected to move forward as one of the first applicants to be granted a license to grow federally legal cannabis under the terms of a new policy statement issued in the Federal Register.
-
MedPharm Holdings Develops Innovative Cannabinoid Infused Dissolvable Oral Strip
1/31/2019
This comes on the heels of a major announcement from publicly traded Medicine Man Technologies (MDCL) to acquire MedPharm Holdings, LLC.
-
VistaGen’s AV-101 Snags Fast Track Designation, Other Drugmakers Move Ahead with Non-Opioid Pain ...
10/6/2018
Opioids have shown tremendous efficacy in pain management. At the same time, the dangers of the addiction to the medication have become well-known in recent years as an epidemic has swept across the United States. -
MedPharm Announce Expansion of Partnership with Palvella Therapeutics in Developing a New Treatment for the Debilitating Rare Disease, Pachyonychia Congenita
10/3/2018
MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation (PTX 022) for applying to the skin as a treatment for pachyonychia congenita
-
Movers and Shakers for Sept. 4
9/4/2018
Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look. -
Virpax Pharmaceuticals Licenses ‘Patch-in-a-Can’ MedSpray® Technology From MedPharm Ltd
5/29/2018
Virpax Pharmaceuticals (“Virpax”), signed a technology license agreement with MedPharm Ltd, to develop non-opioid pain management products delivered via “Patch-in-a-Can” MedSpray® technology.
-
MedPharm Receives Growth Equity Investment from Ampersand Capital Partners
3/26/2018
MedPharm Ltd., a leading provider of contract topical and transdermal product design and formulation development services, is pleased to announce an investment by Ampersand Capital Partners.
-
MedPharm Announces 60% Expansion of its Formulation Development Laboratory Facilities
2/14/2018
The expansion is to accommodate the new scientists needed to service the increase in demand for its formulation development, performance testing and manufacturing services.
-
MedPharm Release: New Research Challenges Current Theories on Skin Penetration of Large Molecular Weight Drugs Offering Hope for the Discovery of New Treatments of Difficult-to-Treat Dermatological Diseases.
11/14/2017
New research, to be published in the Journal of Investigative Dermatology by UK and US scientists this month, challenges current theories on the permeation and penetration of large molecular weight molecules across and into human skin.
-
As U.S. Facilities Investment Starts To Pay Off, Leading Global Product Development Services Provider MedPharm Ltd Strengthens Senior Management Positions
9/7/2017
-
World Leading Drug Formulation Specialist MedPharm Ltd Opens U.S. Facility In Research Park Triangle To Service Growing Dermatology Market
9/28/2016
-
Topical Formulation Specialist MedPharm Ltd Aims High With New £.5 Million UK GMP Facility
10/3/2013
-
MedPharm Ltd Granted New Patents for Topical Spray-on-Film Technology, MedSpray®
8/6/2013
-
MedPharm Ltd Granted New Patents for Topical Spray-On-Film Technology, MedSpray®
8/5/2013